Regencell Bioscience Holdings Ltd (RGC) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-05-22 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-05-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-05-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-05-08 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-04-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-03-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-03-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-02-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-06-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-06-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-06-17 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-06-02 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-01-15 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-06-20 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-01-02 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.